Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.

× No keyword cloud information.

13 in total

1. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Authors: A Nagy; A V Schally; P Armatis; K Szepeshazi; G Halmos; M Kovacs; M Zarandi; K Groot; M Miyazaki; A Jungwirth; J Horvath
Journal: Proc Natl Acad Sci U S A Date: 1996-07-09 Impact factor: 11.205

Review 2. Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors: B P Ram; P Tyle
Journal: Pharm Res Date: 1987-06 Impact factor: 4.200

Review 3. Antibodies as specific carriers for chemotherapeutic agents.

Authors: F H Lee; K M Hwang
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

4. Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

Authors: N Yagi; Y Ogawa; M Kodaka; T Okada; T Tomohiro; T Konakahara; H Okuno
Journal: Lipids Date: 2000-06 Impact factor: 1.880

5. A low density lipoprotein-methotrexate covalent complex and its activity against L1210 cells in vitro.

Authors: G W Halbert; J F Stuart; A T Florence
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

6. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Authors: A Trouet; M Masquelier; R Baurain; D Deprez-De Campeneere
Journal: Proc Natl Acad Sci U S A Date: 1982-01 Impact factor: 11.205

Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.

1. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Review 2. Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Review 3. Antibodies as specific carriers for chemotherapeutic agents.

4. Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

5. A low density lipoprotein-methotrexate covalent complex and its activity against L1210 cells in vitro.

6. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

Review 7. A review of coumarin derivatives in pharmacotherapy of breast cancer.

8. Melanotropin receptors demonstrated in situ in human melanoma.

Review 9. Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Review 10. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.